NCT06519422: Tranexamic Acid for Anaemia Trial
- State
- Under way
- Phase
- Phase 3
- People
- 4,000 planned
- Started
- 10 Aug 2026
- Primary completion
- Aug 2028
- Arms
- Tranexamic acid (TXA)
- Results
- None posted
- 25 Jul 2024: Trial registered
- 10 Aug 2026: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Also known as Cyclo-f, Cyklokapron, Espercil, Femstrual, Haematrix, Lysteda, Rikavarin, TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, Transamin, Tranexamic Acid 500 MG, Tranexamic acid tablets.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.